A cross sectional survey to evaluate knowledge, attitudes and practices regarding seasonal influenza and influenza vaccination among diabetics in Pretoria, South Africa Olatunbosun OD, Esterhuizen TM, Wiysonge CS. Vaccine 2017; 35: 6375-6386.
Introduction
• Influenza is responsible for significant levels of illness, hospitalisation and death and is the most common vaccine-preventable illness in all age groups worldwide. p1a • Approximately 5-10% of adults and 20-30% of children will suffer from influenza each year, and annually influenza accounts for 3-5 million cases of severe illness and approximately 250 000-500 000 deaths. p1b,c • In the influenza season, high levels of morbidity and mortality are seen among individuals aged ≥65 years and those with chronic illness (e.g., diabetes mellitus). p1d • In South Africa, the prevalence of diabetes mellitus among the adult population (20-79 years of age) is approximately 7% and diabetes mellitus is the 3 rd leading cause of death. p1e
• People with diabetes are 3-6 times more likely than those without to be hospitalised with complications of influenza and death rates among diabetics increase by 5-15% during influenza epidemics. p1f • The influenza season in South Africa occurs in the four winter months (May toAugust) and may extend into September. During this time, it is estimated that influenza-related complications may be responsible for between approximately 6 700 and 11 600 deaths. p2g,h • In the USA, during the influenza season, influenza is responsible for 45% of work days lost and 49% of low productivity days among working adults aged 50-64 years. p2i • Vaccination is the most effective method by which to prevent influenza infection and related complications, and in patients with diabetes may reduce hospitalisation for influenza-related illness by almost 80%. p2j,k • The United States Advisory Committee on Immunisation Practices and International Diabetes Federation recommend that diabetics of all ages should be vaccinated with the influenza vaccine. Nevertheless, in Africa influenza vaccination supply and coverage remain low and, in South Africa in 2005 the rate of influenza vaccination coverage among adults older than 17 years was estimated at only 9%. p2 l,m • There is no recent study evaluating the knowledge, attitudes and practices (KAPs) of South Africans with diabetes regarding seasonal influenza and influenza vaccination and evaluating vaccine uptake in this group. p2m
Study purpose p2n,o
Cross sectional survey at two government tertiary hospitals in Pretoria, South Africa. 1. To assess knowledge, attitudes and practices among diabetic patients in Pretoria regarding seasonal influenza and influenza vaccination; and 2. To assess uptake of seasonal influenza vaccination among diabetics and identify factors influencing such practices.
Study design p2 o,p,q,r Cross sectional survey of 292 patients with type 1 or type 2 diabetes, aged >18 years who were attending the weekly endocrine or diabetic clinic between October 2015 and December 2015. Patients in admission and at the emergency departments were excluded.
Results
The mean age of the participants was 49 years (standard deviation 14.25 years). p2s
The majority were black (83%). p2t 24% of respondents had been previously admitted to hospital for flu-related illness. p2w
The percentages of respondents with specific beliefs about influenza are shown in Table 1 . Although only 38% of patients had good knowledge about seasonal flu and 11% had good knowledge about the flu vaccine, the majority of respondents (69%) had a positive attitude towards the flu vaccine. p3b
General attitudes towards the vaccine are listed in Table 2 . Table 2 . General attitudes towards the flu vaccine Belief Percentage All patients (n=292) p3c 1. Annual flu vaccination is important among diabetics 65% 2. Would recommend flu vaccine for all diabetics 65% 3. If there is an effective vaccine, I will take it 81% Responses by patients who had previously received the flu vaccine (n=84) p3d 1. Receive the flu vaccine annually 81% 2. Receive the flu vaccine every 2 years 11% 3. Have only ever received the flu vaccine once 5% 4. Received vaccination on advice from doctor 98% Reasons for not receiving flu vaccine (n=208) p3e 1. Use of alternative protection 51% 2. Vaccination is not necessary, because flu is a minor illness 45%
Vaccine is expensive 31%
Factors that were significantly associated with receiving the flu vaccine are listed in Table 3 . 
Conclusions and discussion
• Sufficient knowledge of the flu vaccine among patients with diabetes is very low (11%). p3g • Only a minority of patients with diabetes had ever received the influenza vaccine (29%). p5a • Even though the majority of patients who have heard about the flu vaccine believe that it is effective and safe, only half of them had ever been vaccinated before. p4h • In general, the patients with diabetes in this study did not regard flu or its complications as being worse among people with diabetes. p4i • The perception of risk may be an important factor for previous vaccination as participants who had received the vaccine had better perception of influenza vaccine preventing serious complications, and a better perception that flu can be prevented. p4j,k • The majority of participants indicated their willingness to receive a vaccine if there is an effective vaccine. p4m • There is a need to educate people with diabetes about the risks associated with influenza and the benefits of annual vaccination. p4n, p5e • Major predictors of vaccination include combined knowledge of vaccine and flu, good attitude towards vaccination, being told about the vaccine by doctors and fellow patients who have previously been vaccinated, and availability of vaccine free of charge. p5b • Vaccination promotion strategies need to focus on encouraging healthcare providers to discuss vaccination with their high-risk clients and in providing them with accurate and unbiased information about the risks of influenza infection and the benefits of vaccination. p5c • Other strategies to improve vaccination that can be employed include client reminder and recall system, community based immunization programme for high risk individuals, public awareness of places where vaccines are available and easy access to influenza vaccine at a subsidised cost. p5d
